Hirsutenone selectively induces cytotoxic effects in human thyroid cancer cells by inhibiting cell migration and invasion, inducing apoptosis and targeting Wnt/beta-catenin signalling pathway

References

• Bialik S, Zalckvar E, Ber Y, Rubinstein AD, Kimchi A. 2010. Systems biology analysis of programmed cell death. Trends Biochem Sci. 35:556–564.
   Web of Science ®Google Scholar
• Chabner BA, Roberts TG Jr. 2005. Timeline: chemotherapy and the war on cancer. Nat Rev Cancer. 5(1):65–72.
   PubMed Web of Science ®Google Scholar
• Cohen GM, Sun XM, Fearnhead H, MacFarlane M, Brown DG, Snowden RT, et al. 1994. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J Immunol. 153:507–516.
   PubMed Web of Science ®Google Scholar
• de Sousa EM, Vermeulen L, Richel D, Medema JP. 2011. Targeting Wnt signaling in colon cancer stem cells. Clin Cancer Res. 17(4):647–653.
   PubMed Web of Science ®Google Scholar
• Drozd VM, Branovan I, Shiglik N, Biko J, Reiners C. 2018. Thyroid cancer induction: nitrates as independent risk factors or risk modulators after radiation exposure, with a focus on the chernobyl accident. Eur Thyroid J. 7:67–74.
   PubMed Web of Science ®Google Scholar
• Farrand L, Kim JY, Byun S, et al. 2014. The diarylheptanoid hirsutenone sensitizes chemoresistant ovarian cancer cells to cisplatin via modulation of apoptosis-inducing factor and X-linked inhibitor of apoptosis. J Biol Chem. 289(3):1723–1731.
   PubMed Web of Science ®Google Scholar
• Genetics of endocrine and neuroendocrine neoplasias (pdq(r)): Health professional version. 2002. In Pdq cancer information summaries; National Cancer Institute (NCI): Bethesda, MD, USA.
   Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell. 144:646–674.
   PubMed Web of Science ®Google Scholar
• Jeong MS, Choi SE, Kim JY, Kim JS, Kim EJ, Park KH, Lee do I, Joo SS, Lee CS, Bang H, et al. 2010. Atopic dermatitis-like skin lesions reduced by topical application and intraperitoneal injection of hirsutenone in NC/Nga mice. Clin Dev Immunol. 2010:article 618517.
   PubMedGoogle Scholar
• JPt M, Wang SC, Hebrok M, Morris John P. 2010. KRAS, hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer. 10(10):683–695.
   PubMed Web of Science ®Google Scholar
• Kang S, Kim JE, Li Y, Jung SK, Song NR, Thimmegowda NR, Kim BY, Lee HJ, Bode AM, Dong Z, Lee KW. 2015. Hirsutenone in Alnus extract inhibits akt activity and suppresses prostate cancer cell proliferation. Mol Carcinog. 54(11):1354–1362.
   Web of Science ®Google Scholar
• Kerr JFR, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257.
   PubMed Web of Science ®Google Scholar
• Kim J, Gosnell JE, Roman SA. 2020. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 16:17–29.
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee KW, Lee MW, Lee HJ, Kim SH, Surh YJ. 2006. Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-kappaB as a potential molecular target. FEBS Lett. 580:385–392.
   PubMed Web of Science ®Google Scholar
• King TD, Suto MJ, Li Y. 2012. The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. J Cell Biochem. 113(1):13–18.
   PubMed Web of Science ®Google Scholar
• Klaus A, Birchmeier W. 2008. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 8(5):387–398.
   PubMed Web of Science ®Google Scholar
• Lai Y-C, Chen C-K, Lin W-W, Lee S-S. 2012. A comprehensive investigation of anti-inflammatory diarylheptanoids from the leaves of Alnus formosana. Phytochemistry. 73:84–94.
   Web of Science ®Google Scholar
• Laubenbacher R, Hower V, Jarrah A, Torti SV, Shulaev V, Mendes P, et al. 2009. A systems biology view of cancer. Biochim Biophys Acta. 1796:129–139.
   PubMed Web of Science ®Google Scholar
• Lee CS, Jang ER, Kim YJ, Myung SC, Kim W, Lee MW. 2012. Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway. Invest New Drugs. 30:548–557.
   PubMed Web of Science ®Google Scholar
• Lee O, Kim J, Choi YW, Lee M, Park G, Oh C. 2013. Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model. Exp Dermatol. 22:832–849.
   Web of Science ®Google Scholar
• Martin SJ, Green DR. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:349–352.
   PubMed Web of Science ®Google Scholar
• Nikiforov YE, Nikiforova MN. 2011. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 7:569–580.
   PubMed Web of Science ®Google Scholar
• Nishida K, Yamaguchi O, Otsu K. 2008. Crosstalk between autophagy and apoptosis in heart disease. Circ Res. 103:343–351.
   PubMed Web of Science ®Google Scholar
• Pardoll DM. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 12(4):252–264.
   PubMed Web of Science ®Google Scholar
• Sanabria A, Kowalski LP, Shah JP, Nixon IJ, Angelos P, Williams MD, Rinaldo A, Ferlito A. 2018. Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis. Head Neck. 40(4):855–866.
   PubMed Web of Science ®Google Scholar
• Sawamura R, Shimizu T, Sun Y, Yasukawa K, Miura M, Toriyama M, Motohashi S, Watanabe W, Konno K, Kurokawa M. 2010. In vitro and in vivo anti-influenza virus activity of diarylheptanoids isolated from alpiniaofficinarum. Antivir Chem Chemoth. 21:33–41.
   Google Scholar
• Seib CD, Sosa JA. 2019. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am. 48(1):23–35.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. 2019 Jan. Cancer statistics, 2019. CA Cancer J Clin. 69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Tan ML, Ooi JP, Ismail N, Moad AI, Muhammad TS. 2009. Programmed cell death pathways and current antitumor targets. Pharmacol Res. 26:1547–1560.
   Google Scholar
• Thongon N, Boonmuen N, Suksen K, Wichit P, Chairoungdua A, Tuchinda P, Suksamrarn A, Winuthayanon W, Piyachaturawat P. 2017. Selective estrogen receptor modulator (SERM)-like activities of diarylheptanoid a phytoestrogen from curcuma comosa, in breast cancer cells, pre-osteoblastcells, and rat uterine tissues. J Agric Food Chem. 65:3490–3496.
   Web of Science ®Google Scholar
• Tian Z, An N, Zhou B, Xiao P, Kohane IS, Wu E. 2009. Cytotoxic diarylheptanoidinduces cell cycle arrest and apoptosis via increasing ATF3 and stabilizingp53 in SH-SY5Y cells. Cancer Chemoth Pharm. 63:1131–1139.
   Web of Science ®Google Scholar
• Tung NH, Kim SK, Ra JC, Zhao YZ, Sohn DH, Kim YH. 2010. Antioxidative and hepatoprotective diarylheptanoids from the bark of Alnus japonica. Planta Med. 76:626–670.
   PubMed Web of Science ®Google Scholar
• Xi Y, Gao H, Callaghan MU, Fribley AM, Garshott DM, Xu Z-X, Zeng Q, Li Y-L. 2015. Induction of BCL2-interacting killer BIK, is mediated for anti-cancer activity of curcumin in human head and neck squamous cell carcinoma cells. J Cancer. 6:327–332.
   PubMed Web of Science ®Google Scholar
• Yang Y, Kinoshita K, Koyama K, Takahashi K, Kondo S, Watanabe K. 2002. Structure-antiemetic-activity of some diarylheptanoids and their analogues. Phytomedicine. 9:146–152.
   PubMed Web of Science ®Google Scholar